MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction

BACKGROUND: Mid-regional pro-atrial natriuretic peptide (MR-proANP) is a useful biomarker in outpatients with type 2 diabetes (T2D) to diagnose heart failure (HF). Elevated B-type natriuretic peptides are included in the definition of HF with preserved ejection fraction (HFpEF) but little is known a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Jesper, Schou, Morten, Kistorp, Caroline, Faber, Jens, Hansen, Tine W., Jensen, Magnus T., Andersen, Henrik U., Rossing, Peter, Vilsbøll, Tina, Jørgensen, Peter G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568388/
https://www.ncbi.nlm.nih.gov/pubmed/33066783
http://dx.doi.org/10.1186/s12933-020-01155-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568388/
https://www.ncbi.nlm.nih.gov/pubmed/33066783
http://dx.doi.org/10.1186/s12933-020-01155-9

Ejemplares similares